Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Trace is partnering with Unlearn as it advances plans for a clinical trial of its treatment candidate that targets the UNC13A ...

A groundbreaking innovation could soon make cancer detection faster, easier, and less invasive. A revolutionary new technology, developed and manufactured in Manchester, could eliminate the need for ...

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

“This blood test clearly identifies Alzheimer’s tau tangles, which is our best biomarker measure of Alzheimer’s symptoms and ...

DMD treatment KER-065 showed a good safety profile in a Phase 1 clinical trial with no serious side effects seen in healthy ...

Longevity experts are mostly over Bryan Johnson's shtick and hope people consider the basics when it comes to taking care of ...

Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer ...

Cognition Therapeutics (CGTX) presented biomarker results from the Phase 2 SHINE study of zervimesine in mild-to-moderate Alzheimer’s disease ...